ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Natural Products

Manus Bio raises $19 million to make plant ingredients via fermentation

by Melody M. Bomgardner
July 15, 2018 | APPEARED IN VOLUME 96, ISSUE 29

Boston-area start-up Manus Bio has raised $19.4 million in its first round of venture funding from investors, including 415 Investments and NXT Ventures. Manus, based on technology developed at MIT, aims to produce ingredients by fermentation that are normally derived from plants. The company is targeting what it calls rare and expensive ingredients used in flavors, fragrances, cosmetics, agriculture, nutrition, and pharmaceuticals. It has disclosed programs to manufacture the stevia sweetener rebaudioside M, the antimalarial artemisinin, and the tick and mite pesticide acaricide.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment